Atlas Trials

Li Zhang, MD

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Li Zhang, MD

RecordFirmDate
Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer (NCT05003037)Li Zhang, MD2022-01-06
Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (NCT05178511)Li Zhang, MD2021-12-01
An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese (NCT05245994)Li Zhang, MD2021-08-21
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations (NCT04695925)Li Zhang, MD2021-03-29
JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy. (NCT04459663)Li Zhang, MD2020-08-31

Track Li Zhang, MD automatically

Every clearance here is in the API, with alerts when new ones post.